Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision notes updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check36 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedA new Revision: v3.4.2 is displayed and an earlier government-funding status notice was removed. The study content, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check72 days agoChange DetectedAdded a government funding notice banner with links to cc.nih.gov and opm.gov. Updated the site software to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check79 days agoChange DetectedShow glossary toggle added and revision/version information updated. Minor capitalization changes to data labels, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.2%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.